Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA‐...
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA‐AF registry
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Until the approval of dabigatran etexilate, treatment choices for stroke prevention in patients with atrial fibrillation (AF) were vitamin K antagonists (VKAs) or antiplatelet drugs. This analysis explored whether availability of non‐vitamin K antagonist oral anticoagulants post‐dabigatran approval was associated with changing treatme...
Alternative Titles
Full title
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA‐AF registry
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2fffc4ffe41f4be588b417b800bc3d2d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2fffc4ffe41f4be588b417b800bc3d2d
Other Identifiers
ISSN
1880-4276
E-ISSN
1883-2148
DOI
10.1002/joa3.12321
